Inhaled Nitric Oxide Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Inhaled Nitric Oxide market size was valued at USD 1115.4 million in 2022 and is forecast to a readjusted size of USD 1904.5 million by 2029 with a CAGR of 7.9% during review period.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%. North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent. In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

This report is a detailed and comprehensive analysis for global Inhaled Nitric Oxide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Inhaled Nitric Oxide market size and forecasts, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2018-2029
Global Inhaled Nitric Oxide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2018-2029
Global Inhaled Nitric Oxide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2018-2029
Global Inhaled Nitric Oxide market shares of main players, shipments in revenue ($ Million), sales quantity (M L), and ASP (US$/L), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhaled Nitric Oxide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Inhaled Nitric Oxide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Mallinckrodt
   Praxair (Linde plc)
   Air Liquide
   BOC Healthcare (Linde Group)

   800 ppm
   100 ppm
   Others

   Near-term and Pre-term Infants PPHN
   Children and Adult ARDS
   Other Diseases
 

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Inhaled Nitric Oxide Market in 2025?

The strength lies in its proven therapeutic efficacy for conditions like pulmonary hypertension and neonatal respiratory distress syndrome. The growing adoption of inhaled nitric oxide for critical care, especially in respiratory diseases, is expected to fuel market growth. Additionally, advancements in delivery systems and increased awareness of its benefits in treating respiratory failure support its market dominance.

What are the weaknesses of the Inhaled Nitric Oxide Market in 2025?

The high cost of treatment and the requirement for specialized equipment pose significant barriers to wider adoption. Additionally, the lack of universal access to inhaled nitric oxide therapies, especially in low-resource settings, limits its growth. There is also a need for better long-term safety data to encourage broader usage.

What opportunities exist for the Inhaled Nitric Oxide Market in 2025?

Increasing prevalence of respiratory diseases and the growing demand for advanced critical care treatments offer substantial growth opportunities. The ongoing research into expanding the clinical indications for inhaled nitric oxide, including potential use in COVID-19 treatment, is expected to open new market avenues. Expansion into emerging markets with improving healthcare infrastructure also presents a major opportunity.

What threats could impact the Inhaled Nitric Oxide Market in 2025?

Regulatory hurdles and the potential for more stringent governmental policies could impact market expansion. Competition from alternative therapies, like prostacyclin analogs and other pulmonary vasodilators, also presents a threat. Economic downturns or healthcare budget cuts in some regions may limit accessibility to high-cost treatments like inhaled nitric oxide.

What are the political factors influencing the Inhaled Nitric Oxide Market in 2025?

Government healthcare policies and regulations around drug approvals, pricing, and reimbursement play a significant role in the growth of the market. Political stability in key markets, particularly in developed countries, supports innovation and investment. However, changes in government policies, especially regarding healthcare budgets, could impact access and affordability.

What are the economic factors affecting the Inhaled Nitric Oxide Market in 2025?

The overall economic conditions, including healthcare spending, economic growth, and disposable income, directly impact the affordability and accessibility of inhaled nitric oxide therapies. High treatment costs and the necessity of specialized equipment could hinder market growth in regions with limited healthcare funding. On the other hand, economic growth in emerging markets presents opportunities for expansion.

How do social factors influence the Inhaled Nitric Oxide Market in 2025?

Increasing awareness of respiratory diseases and the growing emphasis on advanced treatment options in healthcare are driving the demand for inhaled nitric oxide. There is also a rising preference for non-invasive treatments, which makes inhaled nitric oxide more attractive. However, social stigma and misinformation about new therapies could affect acceptance in some populations.

What are the technological factors impacting the Inhaled Nitric Oxide Market in 2025?

Advancements in medical devices and delivery systems, such as portable and efficient inhalers, are enhancing the administration of inhaled nitric oxide. Innovations in monitoring and safety systems are also improving treatment outcomes. However, there is a need for continued research to optimize dosing and delivery mechanisms to ensure the best clinical results.

What are the environmental factors affecting the Inhaled Nitric Oxide Market in 2025?

Environmental regulations around the production and disposal of medical gases could affect production costs and supply chain dynamics. Additionally, a growing emphasis on sustainable healthcare practices could lead to innovations aimed at reducing the environmental impact of the production and use of inhaled nitric oxide therapies.

What legal factors influence the Inhaled Nitric Oxide Market in 2025?

Strict regulatory frameworks for drug approval and safety standards, especially in regions like the U.S. and Europe, impact the time-to-market for inhaled nitric oxide products. Intellectual property laws also influence market competition, with patent protections shaping the competitive landscape. Legal challenges around reimbursement and market access can also limit the growth of new treatments in certain regions.

Who are the suppliers in the Inhaled Nitric Oxide Market in 2025?

The suppliers include manufacturers of nitric oxide, medical gas suppliers, equipment manufacturers for delivery systems (such as inhalers), and companies involved in the production of medical-grade components and technologies required for the administration of inhaled nitric oxide.

What are the inputs required in the Inhaled Nitric Oxide Market in 2025?

Inputs include high-purity nitric oxide gas, medical devices (like delivery systems and inhalation equipment), research and development efforts for clinical applications, regulatory compliance, and human resources for manufacturing, distribution, and administration.

What are the processes involved in the Inhaled Nitric Oxide Market in 2025?

Processes involve the production of nitric oxide gas, development and manufacturing of medical devices for its delivery, regulatory approval for use in clinical settings, distribution to healthcare providers, and the ongoing monitoring and assessment of treatment outcomes in patients.

Who are the customers in the Inhaled Nitric Oxide Market in 2025?

Customers include hospitals, healthcare providers, neonatal care units, pulmonologists, critical care physicians, and ultimately patients with respiratory conditions like pulmonary hypertension and neonatal respiratory distress syndrome who benefit from inhaled nitric oxide therapy.

What are the outputs in the Inhaled Nitric Oxide Market in 2025?

Outputs consist of therapeutic nitric oxide treatments, medical delivery devices, clinical data on efficacy and safety, regulatory approvals, and post-treatment healthcare outcomes. The market also produces research findings that guide further clinical applications and advancements in treatment protocols.

How strong is the threat of new entrants in the Inhaled Nitric Oxide Market in 2025?

The threat of new entrants is moderate. While there is potential for growth in the inhaled nitric oxide market, the high capital investment, regulatory hurdles, and technical expertise required to produce medical-grade nitric oxide and delivery systems make it difficult for new players to enter easily. Additionally, established players have strong brand loyalty and market dominance.

How intense is the bargaining power of suppliers in the Inhaled Nitric Oxide Market in 2025?

The bargaining power of suppliers is moderate. Key suppliers of nitric oxide gas and specialized medical devices hold significant leverage, but the market has a variety of suppliers for components like delivery systems. However, the reliance on high-purity nitric oxide and the complexity of medical equipment means that suppliers with exclusive technologies or patents can exert more influence.

How strong is the bargaining power of buyers in the Inhaled Nitric Oxide Market in 2025?

The bargaining power of buyers is moderate to high. Healthcare providers, such as hospitals and critical care units, have significant buying power due to bulk purchasing and the ability to negotiate pricing for high-cost treatments. However, the limited alternatives for inhaled nitric oxide therapy in certain medical conditions reduces the bargaining power of buyers to some extent.

How intense is the threat of substitute products in the Inhaled Nitric Oxide Market in 2025?

The threat of substitutes is moderate. While there are other pulmonary vasodilators and treatments for respiratory conditions, inhaled nitric oxide offers unique therapeutic benefits, particularly in neonatal and critical care settings. However, advancements in alternative therapies may pose a threat in the future if they prove more cost-effective or accessible.

How competitive is the rivalry among existing players in the Inhaled Nitric Oxide Market in 2025?

The rivalry among existing players is high. The market is dominated by a few established companies with strong product portfolios, but the presence of ongoing research, technological advancements, and potential for market expansion leads to intense competition. Companies are vying to capture larger shares through innovations, pricing strategies, and expanding into new regions.

What are the key raw materials required for the Inhaled Nitric Oxide Market in 2025?

The key raw material is high-purity nitric oxide gas, which is produced through chemical processes such as the oxidation of ammonia. Other materials include medical-grade delivery devices, which require components like valves, regulators, and specialized tubing. Additionally, equipment for monitoring and administering the gas is critical.

Who are the key suppliers involved in the Inhaled Nitric Oxide Market in 2025?

Key suppliers include manufacturers of high-purity nitric oxide gas, medical equipment suppliers for delivery systems and inhalation devices, and companies involved in producing the specialized components and technology used in nitric oxide administration. These suppliers often have established relationships with healthcare facilities and regulatory bodies.

What are the key technologies and processes involved in the upstream segment of the Inhaled Nitric Oxide Market in 2025?

Technologies involved include advanced gas production processes for ensuring the purity of nitric oxide, as well as the development of efficient and portable delivery systems for patient administration. There are also innovations in safety and monitoring equipment, which help ensure the proper dosage and manage side effects. Additionally, research and development in improving the overall delivery efficacy and stability of nitric oxide are critical processes.

How do regulatory requirements affect the upstream segment of the Inhaled Nitric Oxide Market in 2025?

Regulatory requirements are a significant factor, as the production of medical-grade nitric oxide and related devices must meet stringent health and safety standards set by agencies such as the FDA, EMA, and other global regulatory bodies. Compliance with these regulations ensures the quality, safety, and efficacy of the product, but it also adds time and cost to the production process.

What are the challenges in the upstream segment of the Inhaled Nitric Oxide Market in 2025?

Challenges include the high cost of producing and maintaining the necessary purity of nitric oxide, which is critical for patient safety. Additionally, the complexity of manufacturing medical-grade delivery systems and maintaining the supply chain for such specialized components can create bottlenecks. Regulatory compliance and the need for continuous research and innovation also present challenges for upstream players.

What is the role of distribution in the Inhaled Nitric Oxide Market in 2025?

Distribution plays a crucial role in ensuring the timely and safe delivery of inhaled nitric oxide therapies to healthcare providers. This includes the transportation of both the nitric oxide gas and the specialized medical equipment required for its administration. Distribution networks must be efficient, meeting the regulatory requirements for handling and transporting medical gases and equipment.

How does logistics impact the Midstream segment of the Inhaled Nitric Oxide Market in 2025?

Logistics is critical, as medical-grade nitric oxide and associated delivery devices are highly sensitive and require precise handling. Temperature control, proper storage, and timely delivery to hospitals, clinics, and critical care units are necessary to maintain product integrity and ensure patient safety. Disruptions in the supply chain can lead to treatment delays, affecting the availability of essential therapies.

What are the key partnerships and collaborations in the Midstream segment of the Inhaled Nitric Oxide Market in 2025?

Key partnerships involve collaborations between gas suppliers, device manufacturers, healthcare providers, and distributors. These partnerships facilitate the seamless delivery of nitric oxide treatments to hospitals and clinics. Additionally, collaborations with regulatory bodies and research institutions help ensure compliance with medical standards and promote the development of advanced delivery systems.

What challenges does the Midstream segment face in the Inhaled Nitric Oxide Market in 2025?

Challenges include ensuring the efficient storage and distribution of medical-grade nitric oxide, which is sensitive to environmental conditions. The complexity of maintaining an uninterrupted supply chain for both gas and devices can be disrupted by logistical issues, regulatory delays, or transportation restrictions. Furthermore, fluctuating demand in different regions can complicate inventory management.

What technological advancements are important in the Midstream segment of the Inhaled Nitric Oxide Market in 2025?

Technological advancements focus on improving the monitoring and tracking of nitric oxide shipments, ensuring compliance with temperature and safety regulations. Innovations in digital tools for real-time inventory management, automated systems for device maintenance, and telemedicine integration for patient monitoring during treatment are also becoming important in improving the efficiency of midstream operations.

How does the demand for inhaled nitric oxide therapy impact the downstream segment in 2025?

The demand for inhaled nitric oxide therapy is expected to rise due to increasing cases of respiratory diseases such as pulmonary hypertension and neonatal respiratory distress syndrome. This drives the downstream market as healthcare providers seek more effective treatments. The demand for inhaled nitric oxide will also be influenced by the expanding clinical applications and growing acceptance of its use in critical care.

What is the role of healthcare providers in the downstream segment of the Inhaled Nitric Oxide Market in 2025?

Healthcare providers, including hospitals, neonatal care units, and critical care centers, are pivotal in the downstream segment. They administer inhaled nitric oxide therapy to patients, ensuring that the treatment is delivered safely and effectively. Their role also includes monitoring treatment outcomes, collecting clinical data, and providing feedback to improve the therapy's use.

How do reimbursement policies affect the downstream segment in 2025?

Reimbursement policies significantly impact the accessibility of inhaled nitric oxide therapy. If insurers and government health programs offer favorable reimbursement for inhaled nitric oxide treatments, it can lead to greater adoption in healthcare settings. However, reimbursement challenges, especially in regions with limited healthcare funding, could restrict market growth and limit patient access.

What are the customer preferences in the downstream segment of the Inhaled Nitric Oxide Market in 2025?

Customers, particularly healthcare providers, prefer treatments that are effective, non-invasive, and safe. Inhaled nitric oxide therapy meets these criteria, especially for neonates and critically ill patients. Providers also seek cost-effective solutions, ease of use, and technologies that offer precise dosing and monitoring to enhance patient care.

What challenges does the downstream segment face in the Inhaled Nitric Oxide Market in 2025?

Challenges include the high cost of inhaled nitric oxide therapy, which may limit its widespread use, especially in lower-income regions. Additionally, there is a need for more robust clinical data to support its effectiveness in new indications. Healthcare providers also face the challenge of ensuring proper administration and monitoring, requiring specialized equipment and trained staff.

Chapter 1, to describe Inhaled Nitric Oxide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inhaled Nitric Oxide, with price, sales, revenue and global market share of Inhaled Nitric Oxide from 2018 to 2023.
Chapter 3, the Inhaled Nitric Oxide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Nitric Oxide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Inhaled Nitric Oxide market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inhaled Nitric Oxide.
Chapter 14 and 15, to describe Inhaled Nitric Oxide sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Inhaled Nitric Oxide
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Inhaled Nitric Oxide Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 800 ppm
       1.3.3 100 ppm
       1.3.4 Others
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Inhaled Nitric Oxide Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Near-term and Pre-term Infants PPHN
       1.4.3 Children and Adult ARDS
       1.4.4 Other Diseases
   1.5 Global Inhaled Nitric Oxide Market Size & Forecast
       1.5.1 Global Inhaled Nitric Oxide Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Inhaled Nitric Oxide Sales Quantity (2018-2029)
       1.5.3 Global Inhaled Nitric Oxide Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Mallinckrodt
       2.1.1 Mallinckrodt Details
       2.1.2 Mallinckrodt Major Business
       2.1.3 Mallinckrodt Inhaled Nitric Oxide Product and Services
       2.1.4 Mallinckrodt Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Mallinckrodt Recent Developments/Updates
   2.2 Praxair (Linde plc)
       2.2.1 Praxair (Linde plc) Details
       2.2.2 Praxair (Linde plc) Major Business
       2.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Product and Services
       2.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Praxair (Linde plc) Recent Developments/Updates
   2.3 Air Liquide
       2.3.1 Air Liquide Details
       2.3.2 Air Liquide Major Business
       2.3.3 Air Liquide Inhaled Nitric Oxide Product and Services
       2.3.4 Air Liquide Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Air Liquide Recent Developments/Updates
   2.4 BOC Healthcare (Linde Group)
       2.4.1 BOC Healthcare (Linde Group) Details
       2.4.2 BOC Healthcare (Linde Group) Major Business
       2.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product and Services
       2.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 BOC Healthcare (Linde Group) Recent Developments/Updates

3 Competitive Environment: Inhaled Nitric Oxide by Manufacturer

   3.1 Global Inhaled Nitric Oxide Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Inhaled Nitric Oxide Revenue by Manufacturer (2018-2023)
   3.3 Global Inhaled Nitric Oxide Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Inhaled Nitric Oxide by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Inhaled Nitric Oxide Manufacturer Market Share in 2022
       3.4.2 Top 6 Inhaled Nitric Oxide Manufacturer Market Share in 2022
   3.5 Inhaled Nitric Oxide Market: Overall Company Footprint Analysis
       3.5.1 Inhaled Nitric Oxide Market: Region Footprint
       3.5.2 Inhaled Nitric Oxide Market: Company Product Type Footprint
       3.5.3 Inhaled Nitric Oxide Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Inhaled Nitric Oxide Market Size by Region
       4.1.1 Global Inhaled Nitric Oxide Sales Quantity by Region (2018-2029)
       4.1.2 Global Inhaled Nitric Oxide Consumption Value by Region (2018-2029)
       4.1.3 Global Inhaled Nitric Oxide Average Price by Region (2018-2029)
   4.2 North America Inhaled Nitric Oxide Consumption Value (2018-2029)
   4.3 Europe Inhaled Nitric Oxide Consumption Value (2018-2029)
   4.4 Asia-Pacific Inhaled Nitric Oxide Consumption Value (2018-2029)
   4.5 South America Inhaled Nitric Oxide Consumption Value (2018-2029)
   4.6 Middle East and Africa Inhaled Nitric Oxide Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Inhaled Nitric Oxide Sales Quantity by Type (2018-2029)
   5.2 Global Inhaled Nitric Oxide Consumption Value by Type (2018-2029)
   5.3 Global Inhaled Nitric Oxide Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Inhaled Nitric Oxide Sales Quantity by Application (2018-2029)
   6.2 Global Inhaled Nitric Oxide Consumption Value by Application (2018-2029)
   6.3 Global Inhaled Nitric Oxide Average Price by Application (2018-2029)

7 North America

   7.1 North America Inhaled Nitric Oxide Sales Quantity by Type (2018-2029)
   7.2 North America Inhaled Nitric Oxide Sales Quantity by Application (2018-2029)
   7.3 North America Inhaled Nitric Oxide Market Size by Country
       7.3.1 North America Inhaled Nitric Oxide Sales Quantity by Country (2018-2029)
       7.3.2 North America Inhaled Nitric Oxide Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Inhaled Nitric Oxide Sales Quantity by Type (2018-2029)
   8.2 Europe Inhaled Nitric Oxide Sales Quantity by Application (2018-2029)
   8.3 Europe Inhaled Nitric Oxide Market Size by Country
       8.3.1 Europe Inhaled Nitric Oxide Sales Quantity by Country (2018-2029)
       8.3.2 Europe Inhaled Nitric Oxide Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Inhaled Nitric Oxide Market Size by Region
       9.3.1 Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Inhaled Nitric Oxide Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Inhaled Nitric Oxide Sales Quantity by Type (2018-2029)
   10.2 South America Inhaled Nitric Oxide Sales Quantity by Application (2018-2029)
   10.3 South America Inhaled Nitric Oxide Market Size by Country
       10.3.1 South America Inhaled Nitric Oxide Sales Quantity by Country (2018-2029)
       10.3.2 South America Inhaled Nitric Oxide Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Inhaled Nitric Oxide Market Size by Country
       11.3.1 Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Inhaled Nitric Oxide Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Inhaled Nitric Oxide Market Drivers
   12.2 Inhaled Nitric Oxide Market Restraints
   12.3 Inhaled Nitric Oxide Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Inhaled Nitric Oxide and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Inhaled Nitric Oxide
   13.3 Inhaled Nitric Oxide Production Process
   13.4 Inhaled Nitric Oxide Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Inhaled Nitric Oxide Typical Distributors
   14.3 Inhaled Nitric Oxide Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Inhaled Nitric Oxide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Inhaled Nitric Oxide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Mallinckrodt Basic Information, Manufacturing Base and Competitors
   Table 4. Mallinckrodt Major Business
   Table 5. Mallinckrodt Inhaled Nitric Oxide Product and Services
   Table 6. Mallinckrodt Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Mallinckrodt Recent Developments/Updates
   Table 8. Praxair (Linde plc) Basic Information, Manufacturing Base and Competitors
   Table 9. Praxair (Linde plc) Major Business
   Table 10. Praxair (Linde plc) Inhaled Nitric Oxide Product and Services
   Table 11. Praxair (Linde plc) Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Praxair (Linde plc) Recent Developments/Updates
   Table 13. Air Liquide Basic Information, Manufacturing Base and Competitors
   Table 14. Air Liquide Major Business
   Table 15. Air Liquide Inhaled Nitric Oxide Product and Services
   Table 16. Air Liquide Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Air Liquide Recent Developments/Updates
   Table 18. BOC Healthcare (Linde Group) Basic Information, Manufacturing Base and Competitors
   Table 19. BOC Healthcare (Linde Group) Major Business
   Table 20. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product and Services
   Table 21. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales Quantity (M L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. BOC Healthcare (Linde Group) Recent Developments/Updates
   Table 23. Global Inhaled Nitric Oxide Sales Quantity by Manufacturer (2018-2023) & (M L)
   Table 24. Global Inhaled Nitric Oxide Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 25. Global Inhaled Nitric Oxide Average Price by Manufacturer (2018-2023) & (US$/L)
   Table 26. Market Position of Manufacturers in Inhaled Nitric Oxide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 27. Head Office and Inhaled Nitric Oxide Production Site of Key Manufacturer
   Table 28. Inhaled Nitric Oxide Market: Company Product Type Footprint
   Table 29. Inhaled Nitric Oxide Market: Company Product Application Footprint
   Table 30. Inhaled Nitric Oxide New Market Entrants and Barriers to Market Entry
   Table 31. Inhaled Nitric Oxide Mergers, Acquisition, Agreements, and Collaborations
   Table 32. Global Inhaled Nitric Oxide Sales Quantity by Region (2018-2023) & (M L)
   Table 33. Global Inhaled Nitric Oxide Sales Quantity by Region (2024-2029) & (M L)
   Table 34. Global Inhaled Nitric Oxide Consumption Value by Region (2018-2023) & (USD Million)
   Table 35. Global Inhaled Nitric Oxide Consumption Value by Region (2024-2029) & (USD Million)
   Table 36. Global Inhaled Nitric Oxide Average Price by Region (2018-2023) & (US$/L)
   Table 37. Global Inhaled Nitric Oxide Average Price by Region (2024-2029) & (US$/L)
   Table 38. Global Inhaled Nitric Oxide Sales Quantity by Type (2018-2023) & (M L)
   Table 39. Global Inhaled Nitric Oxide Sales Quantity by Type (2024-2029) & (M L)
   Table 40. Global Inhaled Nitric Oxide Consumption Value by Type (2018-2023) & (USD Million)
   Table 41. Global Inhaled Nitric Oxide Consumption Value by Type (2024-2029) & (USD Million)
   Table 42. Global Inhaled Nitric Oxide Average Price by Type (2018-2023) & (US$/L)
   Table 43. Global Inhaled Nitric Oxide Average Price by Type (2024-2029) & (US$/L)
   Table 44. Global Inhaled Nitric Oxide Sales Quantity by Application (2018-2023) & (M L)
   Table 45. Global Inhaled Nitric Oxide Sales Quantity by Application (2024-2029) & (M L)
   Table 46. Global Inhaled Nitric Oxide Consumption Value by Application (2018-2023) & (USD Million)
   Table 47. Global Inhaled Nitric Oxide Consumption Value by Application (2024-2029) & (USD Million)
   Table 48. Global Inhaled Nitric Oxide Average Price by Application (2018-2023) & (US$/L)
   Table 49. Global Inhaled Nitric Oxide Average Price by Application (2024-2029) & (US$/L)
   Table 50. North America Inhaled Nitric Oxide Sales Quantity by Type (2018-2023) & (M L)
   Table 51. North America Inhaled Nitric Oxide Sales Quantity by Type (2024-2029) & (M L)
   Table 52. North America Inhaled Nitric Oxide Sales Quantity by Application (2018-2023) & (M L)
   Table 53. North America Inhaled Nitric Oxide Sales Quantity by Application (2024-2029) & (M L)
   Table 54. North America Inhaled Nitric Oxide Sales Quantity by Country (2018-2023) & (M L)
   Table 55. North America Inhaled Nitric Oxide Sales Quantity by Country (2024-2029) & (M L)
   Table 56. North America Inhaled Nitric Oxide Consumption Value by Country (2018-2023) & (USD Million)
   Table 57. North America Inhaled Nitric Oxide Consumption Value by Country (2024-2029) & (USD Million)
   Table 58. Europe Inhaled Nitric Oxide Sales Quantity by Type (2018-2023) & (M L)
   Table 59. Europe Inhaled Nitric Oxide Sales Quantity by Type (2024-2029) & (M L)
   Table 60. Europe Inhaled Nitric Oxide Sales Quantity by Application (2018-2023) & (M L)
   Table 61. Europe Inhaled Nitric Oxide Sales Quantity by Application (2024-2029) & (M L)
   Table 62. Europe Inhaled Nitric Oxide Sales Quantity by Country (2018-2023) & (M L)
   Table 63. Europe Inhaled Nitric Oxide Sales Quantity by Country (2024-2029) & (M L)
   Table 64. Europe Inhaled Nitric Oxide Consumption Value by Country (2018-2023) & (USD Million)
   Table 65. Europe Inhaled Nitric Oxide Consumption Value by Country (2024-2029) & (USD Million)
   Table 66. Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Type (2018-2023) & (M L)
   Table 67. Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Type (2024-2029) & (M L)
   Table 68. Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Application (2018-2023) & (M L)
   Table 69. Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Application (2024-2029) & (M L)
   Table 70. Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Region (2018-2023) & (M L)
   Table 71. Asia-Pacific Inhaled Nitric Oxide Sales Quantity by Region (2024-2029) & (M L)
   Table 72. Asia-Pacific Inhaled Nitric Oxide Consumption Value by Region (2018-2023) & (USD Million)
   Table 73. Asia-Pacific Inhaled Nitric Oxide Consumption Value by Region (2024-2029) & (USD Million)
   Table 74. South America Inhaled Nitric Oxide Sales Quantity by Type (2018-2023) & (M L)
   Table 75. South America Inhaled Nitric Oxide Sales Quantity by Type (2024-2029) & (M L)
   Table 76. South America Inhaled Nitric Oxide Sales Quantity by Application (2018-2023) & (M L)
   Table 77. South America Inhaled Nitric Oxide Sales Quantity by Application (2024-2029) & (M L)
   Table 78. South America Inhaled Nitric Oxide Sales Quantity by Country (2018-2023) & (M L)
   Table 79. South America Inhaled Nitric Oxide Sales Quantity by Country (2024-2029) & (M L)
   Table 80. South America Inhaled Nitric Oxide Consumption Value by Country (2018-2023) & (USD Million)
   Table 81. South America Inhaled Nitric Oxide Consumption Value by Country (2024-2029) & (USD Million)
   Table 82. Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Type (2018-2023) & (M L)
   Table 83. Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Type (2024-2029) & (M L)
   Table 84. Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Application (2018-2023) & (M L)
   Table 85. Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Application (2024-2029) & (M L)
   Table 86. Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Region (2018-2023) & (M L)
   Table 87. Middle East & Africa Inhaled Nitric Oxide Sales Quantity by Region (2024-2029) & (M L)
   Table 88. Middle East & Africa Inhaled Nitric Oxide Consumption Value by Region (2018-2023) & (USD Million)
   Table 89. Middle East & Africa Inhaled Nitric Oxide Consumption Value by Region (2024-2029) & (USD Million)
   Table 90. Inhaled Nitric Oxide Raw Material
   Table 91. Key Manufacturers of Inhaled Nitric Oxide Raw Materials
   Table 92. Inhaled Nitric Oxide Typical Distributors
   Table 93. Inhaled Nitric Oxide Typical Customers

List of Figures

   Figure 1. Inhaled Nitric Oxide Picture
   Figure 2. Global Inhaled Nitric Oxide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Inhaled Nitric Oxide Consumption Value Market Share by Type in 2022
   Figure 4. 800 ppm Examples
   Figure 5. 100 ppm Examples
   Figure 6. Others Examples
   Figure 7. Global Inhaled Nitric Oxide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Inhaled Nitric Oxide Consumption Value Market Share by Application in 2022
   Figure 9. Near-term and Pre-term Infants PPHN Examples
   Figure 10. Children and Adult ARDS Examples
   Figure 11. Other Diseases Examples
   Figure 12. Global Inhaled Nitric Oxide Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Inhaled Nitric Oxide Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Inhaled Nitric Oxide Sales Quantity (2018-2029) & (M L)
   Figure 15. Global Inhaled Nitric Oxide Average Price (2018-2029) & (US$/L)
   Figure 16. Global Inhaled Nitric Oxide Sales Quantity Market Share by Manufacturer in 2022
   Figure 17. Global Inhaled Nitric Oxide Consumption Value Market Share by Manufacturer in 2022
   Figure 18. Producer Shipments of Inhaled Nitric Oxide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 19. Top 3 Inhaled Nitric Oxide Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Top 6 Inhaled Nitric Oxide Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Global Inhaled Nitric Oxide Sales Quantity Market Share by Region (2018-2029)
   Figure 22. Global Inhaled Nitric Oxide Consumption Value Market Share by Region (2018-2029)
   Figure 23. North America Inhaled Nitric Oxide Consumption Value (2018-2029) & (USD Million)
   Figure 24. Europe Inhaled Nitric Oxide Consumption Value (2018-2029) & (USD Million)
   Figure 25. Asia-Pacific Inhaled Nitric Oxide Consumption Value (2018-2029) & (USD Million)
   Figure 26. South America Inhaled Nitric Oxide Consumption Value (2018-2029) & (USD Million)
   Figure 27. Middle East & Africa Inhaled Nitric Oxide Consumption Value (2018-2029) & (USD Million)
   Figure 28. Global Inhaled Nitric Oxide Sales Quantity Market Share by Type (2018-2029)
   Figure 29. Global Inhaled Nitric Oxide Consumption Value Market Share by Type (2018-2029)
   Figure 30. Global Inhaled Nitric Oxide Average Price by Type (2018-2029) & (US$/L)
   Figure 31. Global Inhaled Nitric Oxide Sales Quantity Market Share by Application (2018-2029)
   Figure 32. Global Inhaled Nitric Oxide Consumption Value Market Share by Application (2018-2029)
   Figure 33. Global Inhaled Nitric Oxide Average Price by Application (2018-2029) & (US$/L)
   Figure 34. North America Inhaled Nitric Oxide Sales Quantity Market Share by Type (2018-2029)
   Figure 35. North America Inhaled Nitric Oxide Sales Quantity Market Share by Application (2018-2029)
   Figure 36. North America Inhaled Nitric Oxide Sales Quantity Market Share by Country (2018-2029)
   Figure 37. North America Inhaled Nitric Oxide Consumption Value Market Share by Country (2018-2029)
   Figure 38. United States Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Canada Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Mexico Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Europe Inhaled Nitric Oxide Sales Quantity Market Share by Type (2018-2029)
   Figure 42. Europe Inhaled Nitric Oxide Sales Quantity Market Share by Application (2018-2029)
   Figure 43. Europe Inhaled Nitric Oxide Sales Quantity Market Share by Country (2018-2029)
   Figure 44. Europe Inhaled Nitric Oxide Consumption Value Market Share by Country (2018-2029)
   Figure 45. Germany Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. France Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. United Kingdom Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Russia Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Italy Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Asia-Pacific Inhaled Nitric Oxide Sales Quantity Market Share by Type (2018-2029)
   Figure 51. Asia-Pacific Inhaled Nitric Oxide Sales Quantity Market Share by Application (2018-2029)
   Figure 52. Asia-Pacific Inhaled Nitric Oxide Sales Quantity Market Share by Region (2018-2029)
   Figure 53. Asia-Pacific Inhaled Nitric Oxide Consumption Value Market Share by Region (2018-2029)
   Figure 54. China Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Japan Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Korea Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. India Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Southeast Asia Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Australia Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. South America Inhaled Nitric Oxide Sales Quantity Market Share by Type (2018-2029)
   Figure 61. South America Inhaled Nitric Oxide Sales Quantity Market Share by Application (2018-2029)
   Figure 62. South America Inhaled Nitric Oxide Sales Quantity Market Share by Country (2018-2029)
   Figure 63. South America Inhaled Nitric Oxide Consumption Value Market Share by Country (2018-2029)
   Figure 64. Brazil Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Argentina Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Middle East & Africa Inhaled Nitric Oxide Sales Quantity Market Share by Type (2018-2029)
   Figure 67. Middle East & Africa Inhaled Nitric Oxide Sales Quantity Market Share by Application (2018-2029)
   Figure 68. Middle East & Africa Inhaled Nitric Oxide Sales Quantity Market Share by Region (2018-2029)
   Figure 69. Middle East & Africa Inhaled Nitric Oxide Consumption Value Market Share by Region (2018-2029)
   Figure 70. Turkey Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Egypt Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Saudi Arabia Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. South Africa Inhaled Nitric Oxide Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Inhaled Nitric Oxide Market Drivers
   Figure 75. Inhaled Nitric Oxide Market Restraints
   Figure 76. Inhaled Nitric Oxide Market Trends
   Figure 77. Porters Five Forces Analysis
   Figure 78. Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide in 2022
   Figure 79. Manufacturing Process Analysis of Inhaled Nitric Oxide
   Figure 80. Inhaled Nitric Oxide Industrial Chain
   Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 82. Direct Channel Pros & Cons
   Figure 83. Indirect Channel Pros & Cons
   Figure 84. Methodology
   Figure 85. Research Process and Data Source